Effect of home-based asthma medication therapy management program on pediatric African Americans with uncontrolled asthma

Ndefo, Uche Anadu; Davis, Portia N.; Henry, Andrea

doi:10.1016/j.japh.2019.03.007

Cited by 6 publications

(20 citation statements)

References 8 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The included studies described program intervention design for the provision of pharmacy clinical services. Studies that were included in the systematic review are summarized in Table 1 9,24‐81 …”

Section: Resultsmentioning

confidence: 99%

“…Of the 59 studies identified, 38 (64.4%) focused solely on a single disease state management intervention, and were therefore determined not to qualify as CMM 9,24,25,27,28,30,31,33,36‐41,44,46,47,52,53,55,57‐59,61,64,66‐72,74,76‐78,80,81 . As shown in Table 2, 18 studies (30.5%) used a CMM approach and included components from all five essential functions of CMM, 26,29,32,34,35,42,43,48‐51,54,60,62,65,73,75,79 while three additional studies (5.1%) were not classified as CMM because they lacked some or all of the essential CMM functions 14,15,45,56,63 .…”

Section: Resultsmentioning

confidence: 99%

“…The overwhelming majority of studies (n = 45; 76.3%) utilized a telephone‐based intervention, either alone or in combination with another mode 9,25‐29,31,34‐42,45‐47,49‐53,55‐58,60‐62,64‐70,73,74,77‐81 . Thirteen studies (22%) used videoconferencing‐based interventions 29,30,32,33,44,48,50,54,63,71,72,75,76 and four studies (6.8%) used web‐based interventions 24,42,43,49 .…”

Section: Resultsmentioning

confidence: 99%

“…Study interventions took place predominantly in a health system setting (n = 26; 44.1%) 9,24,25,27,30‐32,35,36,38‐40,42,43,48,50,52,59,61,62,67,68,70,74,79,81 or ambulatory care clinic (n = 11; 18.6%), 37,46,53,55,58,63,64,66,72,76,78 while seven studies (11.9%) were conducted in a community pharmacy setting 26,47,60,65,69,71,73 . Notably, two studies were conducted in mail‐order pharmacy settings separate from community pharmacies, 51,80 two studies in a national medical health insurance program (ie, Medicare and Medicaid), 56,57 and one in the Express Scripts pharmacy benefit management (PBM) organization 41 . Two studies took place in multiple practice settings 45,54 and eight studies included settings outside of those previously described 28,29,33,34,44,49,75,77 …”

Section: Resultsmentioning

confidence: 99%

See 3 more Smart Citations

Describing the delivery of clinical pharmacy services via telehealth: A systematic review

Melton

Jasmin

Johnson

et al. 2021

J Am Coll Clin Pharm

View full text Add to dashboard Cite

IntroductionTelehealth offers a promising opportunity for the delivery of clinical pharmacy services by increasing the accessibility of health care, extending the reach of clinical services, and allowing pharmacists to engage with patients who might otherwise be overlooked. The objectives of the project were to discover effective strategies for the delivery of clinical pharmacy services via telehealth and to identify core components of comprehensive medication management (CMM) that are deliverable via telehealth.MethodsA systematic literature review was performed by searching four databases (Cumulative Index to Nursing and Allied Health Literature [CINAHL], PubMed, Scopus, and Web of Science) for relevant citations using keywords and subject headings relating to telemedicine, clinical pharmacy services, and health conditions. Studies were eligible for inclusion in the review if the interventions they describe involved telehealth technologies and pharmacist care. Blind screening of abstracts and full‐text review was completed by six researchers divided into teams of two. Any discrepancies were resolved by the corresponding author.ResultsFifty‐nine studies met the inclusion criteria, most (n = 53) of which were conducted in the U.S. Five studies (8.5%) reported pharmacist training as an implementation strategy. The telehealth technologies most regularly utilized were telephone‐based interventions (n = 45), videoconferences (n = 13), and web‐based (n = 4) interventions, with five studies using a combination of technologies. Most studies focused on hypertension (n = 22), diabetes (n = 20), or lipid‐related (n = 14) disease state management. Eighteen studies qualified as CMM (n = 18), with most involving all five essential CMM functions.ConclusionThis systematic review study highlights opportunities for pharmacists to deliver clinical pharmacy services using telehealth. The majority of clinical pharmacy services described in the accessed literature was provided via telephone and focused on targeted monitoring of disease states. While studies reporting the use of CMM interventions were limited, there is an opportunity to increase the application of CMM principles as healthcare systems transition to providing more telehealth services.

show abstract

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

See 2 more Smart Citations

Describing the delivery of clinical pharmacy services via telehealth: A systematic review

Melton

Jasmin

Johnson

et al. 2021

J Am Coll Clin Pharm

View full text Add to dashboard Cite

show abstract

“…[8][9][10] Pharmacist-led cognitive interventions have proven to be valuable tools to improve health services utilization and outcomes in pediatric patients with asthma. 11,12 The pharmaceutical care incentive (PCI) programs are examples of managed care initiatives that sponsor pharmacist-led interventions.…”

Section: What This Study Addsmentioning

confidence: 99%

Impact of a pharmaceutical care incentive program on the asthma medication ratio among pediatric patients with persistent asthma enrolled in a Medicaid program

Hernández‐Muñoz

Kamdar

Zhong

et al. 2021

JMCP

View full text Add to dashboard Cite

show abstract

A review of pharmacy‐led interventions: identification of facilitators and barriers for the design of a new model of care for asthma

Rajballi‐Naidoo,

Wilby,

Young

et al. 2023

Pharmacy Practice and Res

View full text Add to dashboard Cite

The objective of this narrative review was to determine the facilitators and barriers identified in pharmacy‐led interventions that improve outcomes in patients with asthma and support the implementation of interventions in practice. EMBASE, Web of Science, Google Scholar, and PubMed were used to identify 17 relevant articles. Seven studies were randomised controlled studies and 10 were one‐arm, pre‐post evaluations of all participants enrolled. Questionnaires assessing asthma control, medicine adherence, and knowledge about asthma were used, while checklists were used to assess inhaler technique. Studies with planned interventions in a clinic or general practice setting and lasting for 6 months (compared to longer interventions of 48 weeks) were more successful in retaining participation in the program. Education was the key intervention in which inhaler technique training was the most common. Knowledge about the disease, its aetiology, trigger factors, and medication used were covered in 10 of the studies. Fifteen of the articles reported an improvement in the asthma of patients receiving intervention by the pharmacist, measured by their asthma control test scores, emergency department visits, or reduced emergency steroid prescriptions. This review highlights five key requirements for the success of pharmacy‐based interventions for asthma management: (a) developing and maintaining a skilled workforce; (b) close proximation of a general practitioner practice or clinic to the pharmacy; (c) patient education on the disease and medicine; (d) structured and standardised intervention and assessment; and (e) length of the intervention suitable to the pharmacist and the patient.

show abstract

Effect of home-based asthma medication therapy management program on pediatric African Americans with uncontrolled asthma

Cited by 6 publications

References 8 publications

Describing the delivery of clinical pharmacy services via telehealth: A systematic review

Describing the delivery of clinical pharmacy services via telehealth: A systematic review

Impact of a pharmaceutical care incentive program on the asthma medication ratio among pediatric patients with persistent asthma enrolled in a Medicaid program

A review of pharmacy‐led interventions: identification of facilitators and barriers for the design of a new model of care for asthma

Contact Info

Product

Resources

About